切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (01) : 68 -74. doi: 10.3877/cma.j.issn.1673-5250.2021.01.010

所属专题: 文献

论著

儿童再发川崎病临床特征分析并文献复习
罗刚, 泮思林(), 纪志娴, 杜占慧   
  • 收稿日期:2020-04-07 修回日期:2021-01-10 出版日期:2021-02-01
  • 通信作者: 泮思林

Clinical feature analysis of recurrent Kawasaki disease in children and literature review

Gang Luo, Silin Pan(), Zhixian Ji, Zhanhui Du   

  • Received:2020-04-07 Revised:2021-01-10 Published:2021-02-01
  • Corresponding author: Silin Pan
  • Supported by:
    National Natural Science Foundation of China(81770316, 81970249)
引用本文:

罗刚, 泮思林, 纪志娴, 杜占慧. 儿童再发川崎病临床特征分析并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(01): 68-74.

Gang Luo, Silin Pan, Zhixian Ji, Zhanhui Du. Clinical feature analysis of recurrent Kawasaki disease in children and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(01): 68-74.

目的

探讨儿童再发川崎病的发生率、临床特征及冠状动脉病变(CAL)发生情况。

方法

选择2010年5月至2019年10月,青岛市妇女儿童医院心脏中心收治的10例再发川崎病患儿为研究对象。回顾性分析这10例患儿的临床病例资料。采用配对t检验、Fisher确切概率法及Wilcoxon符号秩和检验,对10例患儿初发与再发时的临床表现、实验室检查结果等进行统计学比较。对国内外儿童再发川崎病相关文献进行文献复习。本研究经青岛市妇女儿童医院伦理委员会批准(审批文号:QFELL-KY-2019-64)。

结果

①本中心2010年1月至2019年12月,川崎病再发率为1.16%(10/865),再发川崎病患儿中,男性患儿为7例、女性为3例。②10例患儿川崎病再发时年龄为(42.0±15.8)个月,初发至再发间隔时间为(12.1±6.2)个月,出院后随访至2020年4月预后良好。③本组川崎病患儿初发与再发时热程,皮疹、淋巴结肿大、球结膜充血、口唇充血及手足硬肿发生率,血清C反应蛋白(CRP)、红细胞沉降率(ESR)、血红蛋白(Hb)、白蛋白、丙氨酸转氨酶(ALT)及天冬氨酸氨基转移酶(AST)水平,以及白细胞及血小板计数比较,差异均无统计学意义(均为P>0.05)。初发与再发时,其CAL发生率比较,差异亦无统计学意义(P>0.05)。④文献复习结果:川崎病再发率为1.3%~3.4%,男性患儿多见,初发患儿年龄为0.4~2.2岁,初发距再发的间隔时间为1.0~3.3年,再发时患儿热程多短于初发时;川崎病患儿初发与再发时CAL发生率分别为6.3%~45.5%、6.3%~60.0%。

结论

再发川崎病多见于5岁以下儿童,并且多发生于初次发病后1.5年内,再发患儿的CAL发生率较初发患儿无明显升高。尚未发现与川崎病再发明确相关的危险因素,婴幼儿期初发川崎病患儿其再发可能性更高。

Objective

To explore the incidence, clinical features and coronary artery lesion (CAL) of recurrent Kawasaki disease.

Methods

From May 2010 to October 2019, a total of 10 children with recurrent Kawasaki disease who admitted to the Heart Center of Qingdao Women and Children′s Hospital were selected as research subjects. Their clinical data were analyzed retrospectively, and comparison with whose initial Kawasaki disease of clinical manifestations and laboratory examination results were conducted by paired t-test, Fisher′s exact probability method and Wilcoxon signed rank sum test. The literatures about children with recurrent Kawasaki disease at home and abroad were reviewed. This study was approved by the Ethics Committee of Qingdao Women and Children′s Hospital (Approval No. QFELL-KY-2019-64).

Results

①From January 2010 to December 2019, the recurrence rate of Kawasaki disease was 1.16% (10/865), among of recurrent Kawasaki disease children, there were 7 males and 3 females. ②The age of 10 children with recurrent Kawasaki disease was (42.0±15.8) months at the time of recurrence, and the interval between the initial onset and recurrence was (12.1±6.2) months. They were followed up from discarge to April 2020, and the prognosis was good. ③Comparison of related indicators: there were no significant differences between 10 children with recurrent Kawasaki disease at the time of initial onset and recurrence in duration of fever, incidence of rash, lymphadenectasis, bulbar conjunctiva hyperremia, lip congestion and scleroma of hands and feet, serum levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), hemoglobin (Hb), albumin, alanine transaminase (ALT) and aspartate aminotransferase (AST), and white blood cell count and platelet count (all P>0.05). Also incidence of CAL (P>0.05). ④Results of literature review: recurrence rate of Kawasaki disease was 1.3%-3.4%, male children were more common, the age of initial onset was 0.4-2.2 years, interval from initial onset to recurrence was 1.0-3.3 years, fever duration of recurrence was shorter than that of initial onset, incidence of CAL of children with Kawasaki disease at the time of initiate and recurrent were 6.3%-45.5% and 6.3%-60.0%, respectively.

Conclusions

Recurrent Kawasaki disease was more common in children under 5 years old, and most of them occurred within 1.5 years after initial onset. The incidence of CAL of children with recurrent Kawasaki disease did not increase significantly compared to their initial onset. No clear risk factors related to recurrence of Kawasaki disease have been found yet. Children with Kawasaki disease in infancy may have a higher risk of recurrence.

表1 本组再发川崎病患儿初发与再发时临床资料比较
表2 儿童再发川崎病相关文献分析
[1]
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-927e999. DOI: 10.1161/CIR.0000000000000484.
[2]
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747-2771. DOI: 10.1161/01.CIR.0000145143.19711.78.
[3]
Bell DM, Morens DM, Holman RC, et al. Kawasaki syndrome in the United States 1976 to 1980[J]. Am J Dis Child, 1983, 137(3): 211-214. DOI: 10.1001/archpedi.1983.02140290003001.
[4]
付培培,杜忠东,潘岳松. 2002—2010年北京儿童医院川崎病住院患儿临床分析[J]. 实用儿科临床杂志,2012, 27(9): 661-664. DOI: 10.3969/j.issn.1003-515X.2012.09.006.
[5]
王宏伟,程佩萱. 川崎病再发10例临床分析及文献复习[J]. 中国实用儿科杂志,2003, 18(2): 96-98. DOI: 10.3969/j.issn.1005-2224.2003.02.015.
[6]
孔东明,邓淑珍,王瑞耕,等. 川崎病再发22例[J]. 实用儿科临床杂志,2012, 27(21): 1668-1669,1690. DOI: 10.3969/j.issn.1003-515X.2012.21.017.
[7]
姚晓利,张静. 儿童再发川崎病77例临床特征回顾性分析[J]. 中国循证儿科杂志,2013, 8(6): 442-446. DOI: 10.3969/j.issn.1673-5501.2013.06.008.
[8]
刘仕成,朴金花,韩燕燕. 再发川崎病13例临床分析[J/CD]. 中华临床医师杂志(电子版), 2010, 4(7): 1123-1124. DOI: 10.3969/cma.j.issn.1674-0785.2010.07.058.
[9]
邹丽霞,龚方戚. 再发川崎病20例临床分析[J]. 中国当代儿科杂志,2008, 10(5): 617-619.
[10]
王珍全,金佳蕙,荣星,等. 再发川崎病17例临床分析[J]. 浙江临床医学,2014, (8): 1279-1280.
[11]
Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey[J]. J Epidemiol, 2012, 22(3): 216-221. DOI: 10.2188/jea.je20110126.
[12]
Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease[J]. J Pediatr, 2008, 153(1): 117-121. DOI: 10.1016/j.jpeds.2007.12.021.
[13]
Kobayashi T, Fuse S, Sakamoto N, et al. A new Z Score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma method in a pediatric population[J]. J Am Soc Echocardiogr, 2016, 29(8): 794-801.e29. DOI: 10.1016/j.echo.2016.03.017.
[14]
Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors[J]. Eur J Pediatr, 2013, 172(12): 1641-1647. DOI: 10.1007/s00431-013-2101-9.
[15]
Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada[J]. Pediatr Int, 2012, 54(3): 383-387. DOI: 10.1111/j.1442-200X.2012.03628.x.
[16]
Kim GB, Park S, Eun LY, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014[J]. Pediatr Infect Dis J, 2017, 36(5): 482-485. DOI: 10.1097/INF.0000000000001474.
[17]
Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease: USA and Japan[J]. Pediatr Int, 2015, 57(6): 1116-1120. DOI: 10.1111/ped.12733.
[18]
de La Harpe M, di Bernardo S, Hofer M, et al. Thirty years of Kawasaki disease: a single-center study at the University Hospital of Lausanne[J]. Front Pediatr, 2019, 7: 11. DOI: 10.3389/fped.2019.00011.
[19]
Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey[J]. J Epidemiol, 2010, 20(4): 302-307. DOI: 10.2188/jea.je20090180.
[20]
Sharma SD, Chaturvedi K, Saini A, et al. Recurrence of coronary artery lesions after complete regression in a peculiar case of Kawasaki disease[J]. Cardiol Young, 2019, 29(5): 714-716. DOI: 10.1017/S1047951119000453.
[21]
罗刚,泮思林,王思宝,等. 儿童再发川崎病临床特征的Meta分析[J]. 中国当代儿科杂志,2020, 22(12): 1306-1312. DOI: 10.7499/j.issn.1008-8830.2009138.
[22]
Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan[J]. Pediatr Infect Dis J, 2008, 27(2): 155-160. DOI: 10.1097/INF.0b013e31815922b5.
[23]
Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan[J]. Acta Paediatr, 2001, 90(1): 40-44. DOI: 10.1080/080352501750064851.
[24]
鲁珊. 儿童2年内川崎病多次复发1例报告[J]. 临床儿科杂志,2016, 34(10): 753-754, 760. DOI: 10.3969/j.issn.1000-3606.2016.10.010.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[6] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[7] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[8] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[9] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[10] 邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[11] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[12] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[13] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[14] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要